Association between Urinary Cadmium-to-Zinc Intake Ratio and Adult Mortality in a Follow-Up Study of NHANES 1988-1994 and 1999-2004
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, Kijoon | - |
dc.contributor.author | Melough, Melissa M. | - |
dc.contributor.author | Sakaki, Junichi R. | - |
dc.contributor.author | Ha, Kyungho | - |
dc.contributor.author | Marmash, Dalia | - |
dc.contributor.author | Noh, Hwayoung | - |
dc.contributor.author | Chun, Ock K. | - |
dc.date.available | 2021-02-22T05:35:56Z | - |
dc.date.issued | 2020-01 | - |
dc.identifier.issn | 2072-6643 | - |
dc.identifier.issn | 2072-6643 | - |
dc.identifier.uri | https://scholarworks.sookmyung.ac.kr/handle/2020.sw.sookmyung/2580 | - |
dc.description.abstract | Cadmium (Cd) is a toxic heavy metal associated with increased mortality, but the effect of zinc (Zn) intake on the association between Cd and mortality is unknown. The objective of this study was to examine the association of urinary Cd to Zn intake ratio (Cd/Zn ratio) and mortality risk. In total, 15642 US adults in NHANES 1988-1994 and 1999-2004 were followed until 2011 (15-year mean follow-up). Of the 5367 total deaths, 1194 were attributed to cancer and 1677 were attributed to CVD. After adjustment for potential confounders, positive associations were observed between urinary Cd and all-cause mortality (HR for highest vs. lowest quartile: 1.38; 95% CI: 1.14-1.68) and cancer mortality (HR: 1.54; CI: 1.05-2.27). Urinary Cd was positively associated with cancer mortality among the lowest Zn consumers, and the association diminished among the highest Zn consumers. Positive relationships were observed between the Cd/Zn ratio and all-cause mortality (HR: 1.54; CI: 1.23-1.93), cancer mortality (HR: 1.65; CI: 1.11-2.47) and CVD mortality (HR: 1.49; CI: 1.18-1.88). In conclusion, these findings indicate that Zn intake may modify the association between Cd and mortality. Furthermore, the Cd/Zn ratio, which was positively associated with mortality from all causes, cancer, and CVD, may be an important predictor of mortality. | - |
dc.language | 영어 | - |
dc.language.iso | ENG | - |
dc.publisher | MDPI | - |
dc.title | Association between Urinary Cadmium-to-Zinc Intake Ratio and Adult Mortality in a Follow-Up Study of NHANES 1988-1994 and 1999-2004 | - |
dc.type | Article | - |
dc.publisher.location | 스위스 | - |
dc.identifier.doi | 10.3390/nu12010056 | - |
dc.identifier.scopusid | 2-s2.0-85077280928 | - |
dc.identifier.wosid | 000516825500056 | - |
dc.identifier.bibliographicCitation | NUTRIENTS, v.12, no.1 | - |
dc.citation.title | NUTRIENTS | - |
dc.citation.volume | 12 | - |
dc.citation.number | 1 | - |
dc.type.docType | Article | - |
dc.description.isOpenAccess | Y | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Nutrition & Dietetics | - |
dc.relation.journalWebOfScienceCategory | Nutrition & Dietetics | - |
dc.subject.keywordPlus | CANCER-MORTALITY | - |
dc.subject.keywordPlus | NATIONAL-HEALTH | - |
dc.subject.keywordPlus | ASPIRIN USE | - |
dc.subject.keywordPlus | ALL-CAUSE | - |
dc.subject.keywordPlus | EXPOSURE | - |
dc.subject.keywordPlus | SUPPLEMENTATION | - |
dc.subject.keywordPlus | SMOKING | - |
dc.subject.keywordPlus | BURDEN | - |
dc.subject.keywordPlus | KIDNEY | - |
dc.subject.keywordPlus | COHORT | - |
dc.subject.keywordAuthor | zinc intake | - |
dc.subject.keywordAuthor | urinary cadmium | - |
dc.subject.keywordAuthor | mortality | - |
dc.subject.keywordAuthor | NHANES | - |
dc.subject.keywordAuthor | urinary Cd | - |
dc.subject.keywordAuthor | Zn intake ratio | - |
dc.identifier.url | https://www.mdpi.com/2072-6643/12/1/56 | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
Sookmyung Women's University. Cheongpa-ro 47-gil 100 (Cheongpa-dong 2ga), Yongsan-gu, Seoul, 04310, Korea02-710-9127
Copyright©Sookmyung Women's University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.